Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice.

Drew AF, Blick TJ, Lafleur MA, Tim EL, Robbie MJ, Rice GE, Quinn MA, Thompson EW.

Gynecol Oncol. 2004 Dec;95(3):437-48.

PMID:
15581944
2.

Virological Methods for the Generation and Characterization of Influenza Viruses with Reduced Sensitivity to 4-Guanidino-Neu5Ac2en.

McKimm-Breschkin JL, Sahasrabudhe A, Blick TJ, Jowett AJ, Bethell RC.

Methods Mol Med. 2000;24:375-82. doi: 10.1385/1-59259-245-7:375.

PMID:
21331924
3.

Biochemical Methods for the Characterization of Influenza Viruses with Reduced Sensitivity to 4-Guanidino-Neu5Ac2en.

Bethell RC, Hart GJ, Blick TJ, Sahasrabudhe A, McKimm-Breschkin JL.

Methods Mol Med. 2000;24:367-74. doi: 10.1385/1-59259-245-7:367.

PMID:
21331923
4.

The interaction of neuraminidase and hemagglutinin mutations in influenza virus in resistance to 4-guanidino-Neu5Ac2en.

Blick TJ, Sahasrabudhe A, McDonald M, Owens IJ, Morley PJ, Fenton RJ, McKimm-Breschkin JL.

Virology. 1998 Jun 20;246(1):95-103.

5.

Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase.

Varghese JN, Smith PW, Sollis SL, Blick TJ, Sahasrabudhe A, McKimm-Breschkin JL, Colman PM.

Structure. 1998 Jun 15;6(6):735-46.

6.

Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors.

McKimm-Breschkin JL, Sahasrabudhe A, Blick TJ, McDonald M, Colman PM, Hart GJ, Bethell RC, Varghese JN.

J Virol. 1998 Mar;72(3):2456-62.

7.

Structural evidence for a second sialic acid binding site in avian influenza virus neuraminidases.

Varghese JN, Colman PM, van Donkelaar A, Blick TJ, Sahasrabudhe A, McKimm-Breschkin JL.

Proc Natl Acad Sci U S A. 1997 Oct 28;94(22):11808-12.

9.

Generation and characterization of variants of NWS/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en.

McKimm-Breschkin JL, Blick TJ, Sahasrabudhe A, Tiong T, Marshall D, Hart GJ, Bethell RC, Penn CR.

Antimicrob Agents Chemother. 1996 Jan;40(1):40-6.

10.

Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en.

Blick TJ, Tiong T, Sahasrabudhe A, Varghese JN, Colman PM, Hart GJ, Bethell RC, McKimm-Breschkin JL.

Virology. 1995 Dec 20;214(2):475-84.

Supplemental Content

Loading ...
Support Center